Abstract
Recent technology advances in multiplex genotyping and high-throughput genomic profiling by next-generation sequencing (NGS) technologies now offer the possibility of rapidly and comprehensively interrogating the cancer genome of individual patients from small tumor biopsies but sufficient data to support the clinical utilization are limited. Surgically resected formalin-fixed paraffin-embedded (FFPE) tumor tissues from 26 consecutive patients with NSCLC with known …
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call